buspirone has been researched along with vorinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cho, M; Choi, E; Han, G; Kang, JS; Kim, HM; Lee, K; Oh, SJ; Park, JE; Park, SK; Seo, JJ; Yoon, HC | 1 |
| Cho, M; Choi, S; Han, G; Jeong, JH; Kang, JS; Kim, H; Kim, HJ; Kim, JH; Lee, C; Oh, SJ; Yang, JS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Han, G; Kang, JS; Kim, HJ; Kook, YJ; Lee, C; Oh, SJ; Song, D | 1 |
1 review(s) available for buspirone and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for buspirone and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Property based optimization of δ-lactam HDAC inhibitors for metabolic stability.
Topics: Animals; Biological Availability; Cell Line, Tumor; Histone Deacetylase Inhibitors; Humans; Lactams; Mice | 2010 |
Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization.
Topics: Acetylation; Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Core Binding Factor Alpha 3 Subunit; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Humans; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Microsomes; Protein Stability; Pyridones; Rats; Rats, Sprague-Dawley; Transcriptional Activation | 2015 |
Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators.
Topics: Acetylation; Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Cell Proliferation; Core Binding Factor Alpha 3 Subunit; Drug Stability; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mice; Microsomes; Protein Stability; Pyridines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2017 |